BDRX (Biodexa Pharmaceuticals plc American Depositary Shs) Stock Analysis - SEC Filings

Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) is a publicly traded Healthcare sector company. As of May 21, 2026, BDRX trades at $3.10 with a market cap of $2.04M and a P/E ratio of 0.00. BDRX moved +0.00% today. Year to date, BDRX is -75.22%; over the trailing twelve months it is -95.29%. Its 52-week range spans $2.86 to $544.50. Rallies surfaces BDRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find BDRX SEC filings?

Rallies organizes BDRX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

BDRX Key Metrics

Key financial metrics for BDRX
MetricValue
Price$3.10
Market Cap$2.04M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$544.50
52-Week Low$2.86
Volume10
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest BDRX News

BDRX Analyst Consensus

BDRX analyst coverage data. Average price target: $0.00.

Common questions about BDRX

Where can I find BDRX SEC filings?
Rallies organizes BDRX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show BDRX 10-K and 10-Q filings?
Rallies organizes BDRX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is BDRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BDRX. It does not provide personalized investment advice.
BDRX

BDRX